Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.91
-0.39 (-1.54%)
At close: Mar 28, 2025, 4:00 PM
24.43
-0.48 (-1.93%)
After-hours: Mar 28, 2025, 4:54 PM EDT
Pacira BioSciences Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$30.67
Upside
+23.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $17 → $24 | Buy | Maintains | $17 → $24 | -3.65% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +28.46% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $70 | Strong Buy | Maintains | $57 → $70 | +181.01% | Feb 28, 2025 |
| Truist Securities | Truist Securities | Strong Sell → Hold Upgrades $8 → $25 | Strong Sell → Hold | Upgrades | $8 → $25 | +0.36% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $18 | Hold | Reiterates | $18 | -27.74% | Jan 14, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +20.43% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +20.43% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +56.56% | Dec 4, 2024 |
| Barclays | Barclays | Hold Maintains $25 → $17 | Hold | Maintains | $25 → $17 | -31.75% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | -11.68% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -35.77% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | -39.78% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | -27.74% | Sep 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Strong Sell Downgrades $30 → $8 | Strong Buy → Strong Sell | Downgrades | $30 → $8 | -67.88% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $37 → $14 | Buy → Hold | Downgrades | $37 → $14 | -43.80% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $39 | Strong Buy | Maintains | $57 → $39 | +56.56% | Aug 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.